What happened to Synergy Pharmaceuticals?
NEW YORK, March 6, 2019 /PRNewswire/ — Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the “Company” or “Synergy”), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today confirmed that the previously announced sale of certain assets to Bausch Health Companies Inc. is now complete.
Are all Synergy products prescription based medicines?
All products consist of 100% natural health supplements, they are not prescription based medicines. It is essential that Synergy continues to meet all regulatory requirements for manufacturing, testing, labeling and certification of our products as a distributor.
Is synergy safe to use?
As an Australian company, Synergy has undertaken rigorous testing and certification to make certain that the products are safe for public consumption. All products consist of 100% natural health supplements, they are not prescription based medicines.
What has synergy been up to at viruses 2020?
Building on this, Synergy were also glad to announce their contribution to the world conference Viruses 2020 – Novel Concepts in Virology held in Barcelona, Spain, 5-7 February 2020.
What is Synergy Pharmaceuticals’ticker symbol?
Synergy Pharmaceuticals trades on the NASDAQ under the ticker symbol “SGYP.” How much money does Synergy Pharmaceuticals make? Synergy Pharmaceuticals has a market capitalization of $0.00 and generates $16.82 million in revenue each year.
How do I contact Synergy Pharmaceuticals?
The biopharmaceutical company can be reached via phone at 212-297-0020 or via email at [email protected]. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.